Information  X 
Enter a valid email address

C&C Group Plc (CCR)

  Print      Mail a friend       Annual reports

Wednesday 06 March, 2019

C&C Group Plc

Holding(s) in Company

RNS Number : 0502S
C&C Group Plc
06 March 2019
 

Standard form for notification of major holdings

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:    C&C Group PLC

 

2. Reason for the notification (please tick the appropriate box or boxes):

[X] An acquisition or disposal of voting rights

[ ] An acquisition or disposal of financial instruments

[ ] An event changing the breakdown of voting rights

[ ] Other (please specify)iii:

 

3. Details of person subject to the notification obligationiv :

Name: Artemis Investment Management LLP on behalf of discretionary funds under management

City and country of registered office (if applicable):

Cassini House, 57 St. James's Street, London, SW1A 1LD

4. Full name of shareholder(s) (if different from 3.)v:

 

5. Date on which the threshold was crossed or reachedvi:

05 March 2019

6. Date on which issuer notified:

06 March 2019

7. Threshold(s) that is/are crossed or reached:

3%

8. Total positions of person(s) subject to the notification obligation:

 

% of voting rights attached to shares (total of 9.A)

% of voting rights through financial instruments
(total of 9.B.1 + 9.B.2)

Total of both in % (9.A + 9.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

3.07%

 

3.07%

311,329,042

Position of previous notification (if applicable)

 

 

 

 

 

9. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii:

A: Voting rights attached to shares

Class/type of
shares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

 

Direct

 

 

Indirect

 

 

Direct

 

 

Indirect

 

IE00B010DT83

 

9,554,828

 

3.07%

SUBTOTAL A

 

9,554,828

 

3.07%

 

B 1: Financial Instruments according to Regulation 17(1)(a) of the Regulations 

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Number of voting rights that may be acquired if the instrument is exercised/converted.

% of voting rights

 

 

 

 

 

 

 

SUBTOTAL B.1

 

 

 

B 2: Financial Instruments with similar economic effect according to Regulation 17(1)(b) of the Regulations

Type of financial instrument

Expiration
date
x

Exercise/
Conversion Period
xi

Physical or cash settlementxii

Number of voting rights

% of voting rights

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

SUBTOTAL B.2

 

 

                   

 

10. Information in relation to the person subject to the notification obligation (please tick the applicable box):

 

[ ] Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuer.xiii

 

[X] Full chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held starting with the ultimate controlling natural person or legal entity
xiv:

 

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

Artemis Investment Management LLP

3.07%

 

3.07%

 

 

 

 

 

11. In case of proxy voting: [name of the proxy holder] will cease to hold [% and number] voting rights as of [date]

 

 

 

12. Additional informationxvi:

 

 


 

 

Done at London on 6th March 2019.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
HOLLLFFLVTIRIIA

a d v e r t i s e m e n t